AmunBio is an early stage biotechnology company developing and commercializing cutting-edge, engineered immunotherapeutic oncolytic viruses for the treatment of cancer and hematological malignancies. With this next-generation proprietary technology platform approach, utilizing direct destruction of cancer cells and immune system activation, patients will be uniquely positioned to defeat cancer.
Copyright © 2022 Amunbio - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.